Dental AI Software: A Buyer's Guide for Practices

The short answer: dental AI software is worth buying, but the category is fragmented enough that buying the wrong tool — or buying the right tool at the wrong moment in your practice’s workflow — is a real risk. This guide gives you a structured way to think through the decision.

What Dental AI Software Actually Covers

The term gets applied to at least four distinct categories, and vendors don’t always make the distinction clear.

Diagnostic imaging AI reads bitewing, periapical, and panoramic radiographs to flag caries, bone levels, periapical lesions, and other pathology. This is the most mature segment — the one with the most FDA clearances, the most peer-reviewed evidence, and the most direct clinical impact.

Treatment planning and case presentation AI takes diagnostic findings and helps build patient-facing visuals or predicts outcomes. AI models can now predict orthodontic treatment outcomes with up to 73% accuracy, according to a 2024 peer-reviewed review in PMC/NIH — useful in standard cases, less reliable in complex ones.

CAD/CAM and restorative AI has quietly become part of most commercial dental CAD/CAM platforms, automating crown design and prosthesis fabrication. If you’re already running a mill, you’re probably already using it.

Front-office AI covers voice-to-chart dictation (Bola AI is one example), phone analytics (Patient Prism analyzes calls and delivers feedback in under 60 seconds, per the vendor), automated insurance verification, and claims processing. The staffing angle matters here: 60% of dentists cited recruitment as their top challenge in 2024, according to DrBicuspid’s trends report, and front-office AI is one tangible way to reduce headcount dependency.

Start by deciding which of these four you actually need. Practices without a clear diagnostic bottleneck don’t need to start with imaging AI; a high-volume front desk with a claims rejection problem might get more immediate return from billing automation.

The FDA Clearance Question

For any diagnostic AI tool, FDA clearance is non-negotiable. As of mid-2025, 13 companies offer a combined 29 FDA-cleared AI products for dental imaging, addressing tasks from caries detection to cephalometric analysis, per a narrative review published on PubMed. That’s a meaningful number — but it also means plenty of platforms are still operating without it.

Per the FDA’s own 510(k) documentation, cleared CADe dental AI devices are indicated as a second reader aid, not a replacement for clinical judgment. That framing matters when you’re explaining AI-assisted findings to patients, and when you’re thinking about liability.

Pearl’s Second Opinion was the first FDA-cleared real-time pathology detection solution for dental X-rays, and subsequently received 510(k) clearance for panoramic radiograph analysis — making it one of the more broadly cleared platforms available. DEXIS AI analyzed over 120 million clinical findings in 2025 alone and is FDA-cleared for up to 14 finding types on 2D intraoral radiographs, according to the vendor. Denti.AI (Toronto) is another cleared platform using convolutional neural networks for tooth numbering, caries detection, periapical lesion identification, and bone level assessment.

For a detailed head-to-head look at two of the leading imaging platforms, see our overjet dental ai comparison.

What the Clinical Evidence Actually Says

A PMC/NIH review on AI-powered dentistry found that some AI diagnostic tools report accuracy rates exceeding 90% for detecting caries and periodontal disease via panoramic radiographs — though evidence quality and methodology vary across platforms. Pearl’s clinical studies — submitted as part of FDA review and comprising four separate studies with 2,000+ radiographic images each — showed that clinicians using AI assistance identified 36% more lesions than those reading without it. That’s a vendor-reported figure from FDA submissions, but the methodology was reviewed by the agency, which gives it more weight than a typical marketing claim.

The honest caveat: peer-reviewed evidence remains variable. A 2024 PMC/NIH analysis of commercial dental AI found that most studies on AI-enabled workflows “lack standardized metrics,” and heterogeneity across platforms limits direct comparisons. Ask any vendor for sample sizes, study design, and whether findings were replicated outside their own research team.

One genuinely interesting data point on the patient side — though this speaks to case acceptance, not clinical performance — is that 92% of patients who viewed AI-produced annotations on their own radiographs said they planned to follow through on recommended treatment, according to vendor-reported figures from Pearl. For practices where case acceptance is a bottleneck, that’s worth noting.

How to Evaluate a Platform Before You Buy

The questions that cut through vendor demos fastest:

• Is it FDA-cleared, and for which specific indications? A clearance for caries detection doesn’t automatically cover bone level assessment.
• How does it integrate with your existing imaging software and practice management system? Most platforms connect via TWAIN, DICOM, or a dedicated bridge — but setup friction varies.
• What does the radiologist or dental school validation look like? Independent clinical validation, not just internal accuracy metrics.
• How are findings presented chairside? Overlays on the radiograph, a separate findings panel, or something that requires switching screens mid-appointment?
• What happens to your patient data? Storage location, HIPAA compliance, and data usage policies for model training vary significantly by vendor.

Pricing is almost never published openly. Expect subscription models ranging from a few hundred to over a thousand dollars per month depending on volume, features, and whether imaging hardware is bundled. Get quotes from at least three vendors.

Where to Start

For most general practices evaluating dental AI software for the first time, diagnostic imaging AI delivers the clearest, most defensible clinical return. The evidence base is stronger, the regulatory framework is clearer, and the workflow integration is more mature than in other segments. Front-office AI is compelling but more vendor-dependent in terms of quality.

Whatever segment you choose, don’t buy based on a demo alone. Request a 30-day trial on live cases and track a metric that matters to your practice — whether that’s findings per exam, time spent on insurance verification, or case acceptance rate. The numbers from your own patient population will tell you more than any benchmark study.

For broader context on how AI fits into the practice technology stack, see our overview of digital dentistry.